Ardent Health Partners, Inc. (ARDT)
NYSE: ARDT · Real-Time Price · USD
13.20
+0.04 (0.30%)
At close: Mar 28, 2025, 4:00 PM
13.16
-0.04 (-0.34%)
After-hours: Mar 28, 2025, 8:00 PM EDT
Ardent Health Partners Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Ardent Health Partners stock have an average target of 21.25, with a low estimate of 18 and a high estimate of 25. The average target predicts an increase of 60.98% from the current stock price of 13.20.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Ardent Health Partners stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Buy | 6 | 6 | 6 | 6 | 7 | 7 |
| Hold | 1 | 2 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 11 | 11 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Buy Reiterates $22 | Buy | Reiterates | $22 | +66.67% | Mar 26, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $23 → $21 | Buy | Maintains | $23 → $21 | +59.09% | Mar 4, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $22 | Buy | Reiterates | $22 | +66.67% | Feb 27, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $24 → $22 | Buy | Maintains | $24 → $22 | +66.67% | Jan 21, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $22 → $21 | Strong Buy | Maintains | $22 → $21 | +59.09% | Jan 6, 2025 |
Financial Forecast
Revenue This Year
6.44B
from 5.97B
Increased by 7.98%
Revenue Next Year
6.82B
from 6.44B
Increased by 5.87%
EPS This Year
1.93
from 1.58
Increased by 22.23%
EPS Next Year
2.06
from 1.93
Increased by 6.92%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 6.7B | 7.1B | 7.5B |
| Avg | 6.4B | 6.8B | 7.2B |
| Low | 6.1B | 6.5B | 6.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 11.9% | 9.7% | 9.7% |
| Avg | 8.0% | 5.9% | 5.9% |
| Low | 2.9% | 1.4% | 1.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.09 | 2.35 | 2.52 |
| Avg | 1.93 | 2.06 | 2.29 |
| Low | 1.77 | 1.80 | 1.99 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 32.2% | 21.8% | 22.0% |
| Avg | 22.2% | 6.9% | 11.0% |
| Low | 12.3% | -6.6% | -3.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.